Certara is a biosimulation and drug-development technology company that employs approximately 550 people across North America, Europe, and other regions. Current staffing data show 48 recent additions to the team and 62 departures, resulting in a slight net decrease in total headcount. The numbers illustrate an organisation that is actively adjusting its workforce while continuing to support a global client base with software, consulting, and regulatory science services.
Engineering is Certara’s largest group with 140 employees, accounting for roughly one-quarter of the workforce and underscoring the company’s emphasis on technology and product development. Marketing & Product (88) and Business Management (86) follow closely, reflecting the importance of go-to-market strategy and corporate operations. Sales & Support (75) and Finance & Administration (35) round out the core commercial and back-office functions, while Operations, IT, and Healthcare collectively represent another 60+ specialists. A further 62 employees are classified under Other roles, and there is no dedicated headcount in Real Estate at this time.
Headcount is widely distributed, with the largest concentration in Philadelphia (73 employees). Additional U.S. hubs include Raleigh-Durham (33), New York (20), Boston (18), Princeton (11), Seattle (10), and St. Louis (13). Internationally, the United Kingdom hosts 18 team members, and the Montreal office counts 10. Another 28 employees work from various remote or field locations, highlighting Certara’s flexible approach to talent placement.